Device Type Segment Analysis: Non-surgical Devices (Largest & Fastest-Growing Segment)

The erectile dysfunction device market was led by the non-surgical devices segment, which accounted for 60% of the market share in 2026 while also emerging as the fastest-growing category. Strong patient preference for minimally invasive treatment options, coupled with the convenience of home-based use, has supported widespread adoption of these devices. Their ability to provide symptom management without surgical intervention appeals to individuals seeking effective solutions with lower procedural risks and shorter recovery periods. Continued improvements in device design, user comfort, and accessibility through healthcare providers are further reinforcing demand, allowing the segment to maintain both its leading position and growth momentum.

Age Group Segment Analysis: 40-60 Years (Largest Segment) vs More Than 60 Years (Fastest-Growing Segment)

Holding the largest share of the erectile dysfunction device market, the 40–60 years age group accounted for 38.66% of the market share in 2026. Individuals within this age range are more likely to seek medical consultation and treatment as lifestyle-related conditions, stress, metabolic disorders, and cardiovascular risk factors increasingly contribute to erectile dysfunction. Greater awareness of available treatment options and a stronger willingness to adopt non-pharmacological therapies have further strengthened the segment's market leadership.

The more than 60 years age group is anticipated to witness the fastest growth due to the rising prevalence of age-associated health conditions that increase the incidence of erectile dysfunction. Improvements in life expectancy, growing acceptance of sexual wellness among older adults, and better access to specialized urological care are encouraging greater adoption of treatment devices. Increasing emphasis on maintaining quality of life and healthy aging is also expected to support sustained expansion of this segment.

Cause Segment Analysis: Diabetes (Largest & Fastest-Growing Segment)

In the erectile dysfunction device market, the diabetes segment held the largest position in 2026 while also representing the fastest-growing category. Diabetes is a major contributor to erectile dysfunction because prolonged metabolic impairment can affect blood vessels and nerve function essential for normal erectile performance. The growing burden of diabetes, combined with increasing diagnosis rates and greater awareness of diabetes-related complications, is encouraging more patients to seek supportive treatment options. As healthcare providers place greater emphasis on comprehensive disease management and quality-of-life improvements, demand for erectile dysfunction devices among diabetic patients continues to strengthen.